Weighing mainstream and alternative accounts…
Nov 18, 2026
Source mix
1 of 9 institutional
Image: nature.com
Mei’s death was hidden from the paper, while regulators found safety warnings and consent failures that should have stopped the trial.
Mei’s death exposed a specific breakdown in clinical safeguards: the team moved ahead despite animal toxicity signals, failed to communicate the risk of death clearly, and omitted the fatal outcome from a later paper. Official action and independent reporting establish serious misconduct in this trial, while the scale of similar failures remains unknown.
Mei, a four-year-old Shanghai child, died after gene editing. Her death vanished from the paper meant to mark a breakthrough.
Mei, a four-year-old Shanghai child, developed fever and kidney failure days after a customized gene-editing treatment, yet the later Nature paper did not mention her death. Investigators found ignored animal-safety warnings, weak consent language, and rule breaches. One case cannot measure the whole system, but it shows how spectacular results can crowd out the risks science needs recorded.
Featured · Primary source · science.org
Exclusive: Death of girl in Chinese gene-editing trial was never made public | Science | AAAS
News reporting
Exclusive: Death of girl in Chinese gene-editing trial was never made public | Science | AAAS # A fatal reaction ## A cutting-edge gene-editing trial in China went disastrously wrong. A family wants accountability - 23 Jul 2026 - 1:00 PM ET - By Brendan Borrell, Retraction Watch DARIA LADA Table of
Read sourcePrimary source · pmc.ncbi.nlm.nih.gov
Adeno-associated virus vectors and neurotoxicity—lessons from preclinical and human studies - PMC
Journal · peer-reviewed
# Adeno-associated virus vectors and neurotoxicity—lessons from preclinical and human studies PMC11247785. Gene therapy, 32(1):60–73. Published 2023-05-10. ## Authors Daniel Stone, Martine Aubert, Keith R. Jerome ## Details - DOI: https://doi.org/10.1038/s41434-023-00405-1 - PMID: 37165032 (https://
Read sourceAnalysis · noemamag.com
What China’s Gene-Editing Deaths Reveal About Its Biotech Industry
Other
BEIJING — In March 2023, four-year-old Mei in Shanghai was diagnosed with a rare genetic mutation linked to developmental delay and autism-like traits. Although her condition was mild and she improved with therapy and special education, her parents remained worried about her future. Hopeful for a cure, they paid Qiu Zilong, a renowned neuroscientist at Shanghai Jiao Tong University, and his team $
Read sourceHHS is loosening peptide rules before FDA scientists can establish whether the drugs are safe.
8 sourcesA mother’s cells can remain in her child’s body for life, even reaching the brain.
7 sourcesA Ghana lab's unguarded AI designed 6,020 toxin candidates, exposing the gap before DNA synthesis.
7 sourcesA Fudan affiliation cost an Idaho State professor his byline, even though the paper itself passed scientific review.
7 sourcesPPARD therapy is emerging to help immune cells outcompete tumors for fuel.
7 sourcesGlioTrace uses AI to track brain cancer cells switching invasion routes, exposing why one treatment may open another path.
4 sources